Now in its 10th year, the World Drug Manufacturing Summit will allow you to meet with a wide range of contacts for a combination of stream sessions, workshops and case studies.
29th November - 1st December 2011
Berlin, Germany
Now in its 10th year, the World Drug Manufacturing Summit will allow you to meet with a wide range of contacts for a combination of stream sessions, workshops and case studies.
Pharmaceutical Technology Europe subscribers get 15% off
Multi-streamed sessions
Varied streams throughout the event allow you to choose the topic area that will be of the most interest to your own organisation allowing you to take away knowledge and best practice specific to your own operations. Streams include:
Operational Excellence - Aligning manufacturing with other functions, achieving a sustainable cultural change and technology transfer efficiency
QBD - Risk based quality management approach, real-time release in pharma manufacturingGlobalisation - Developing manufacturing in emerging markets, overcoming the cultural and regulatory barriers
COGS reduction - Cost-effective processes, impact of cost of drug development and Cost of Goods Sold
Facility management and engineering - Flexible, multi-product manufacturing facilities, efficient energy and water management, integrating the latest technologies and continuous manufacturing
Manufacturing IT - Effective data management to improve control and decision making, implementing MES, PAT and automation
To download the full programme please email martin.fewster@wtgevents.com.
Speaker panel
Speakers at the summit represent a wide variety of organisations from across the pharmaceutical manufacturing industry including:
Register
To register your place now visit www.wdmsummit.com/PTEE1, call +44 (0)20 7202 7690 or email enquire@wtgevents.com for the special 15% discount courtesy of Pharmaceutical Technology Europe.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.